Solvestrols at work

1623 Posts | Page(s): Prev 12...73 74 75 76 77 ...162163 Next 

RE: Salvestrol

by Shemay on Thu Mar 21, 2013 01:22 AM

Quote | Reply
Hi Macdon from another Coast to Coast fan.  That program gets so interesting at times it keeps me awake some nights.
For anyone who doubts Big Pharma and Big Medicine have funded shills whose main purpose is to discredit and bring costly, fraudulent lawsuits against alternative medicine practitioners and others in an attempt to bankrupt them and put them out of business here's one example..... read on: 
ReStephen Barrett
"Amidst the morass of fallacious attacks by mainstream medicine on honest alternative approaches to health, now and then there's a glitter of good news. It's a breath of fresh air to announce that the self-styled Quackbusters, headed by a self-styled psychiatrist who failed his exam and was never accepted into the profession, has fallen to one of its targeted victims."

Evil personified IMHO.

RE: Salvestrol

by calin on Thu Mar 21, 2013 01:30 AM

Quote | Reply

I am Coast to Coast listener too. I have a membership so I can catch up on the shows while I work the next day.

There is something about Caldwell that bugs me.

RE: Salvestrol

by Macdon on Fri Mar 22, 2013 12:51 AM

Quote | Reply

I think we should get back on track and find out how to make salvestrols work in 100% of people. That is, can we find supplements to help with the malfunctioning cytochrome P450 enzymes?

My first thoughts on this are supplementary enzymes since cytochrome P450 are a group of enzymes.

Enzyme therapy is also proposed as a cure for not just cancer, but many other diseases.

What follows is an excerpt from The Complete Guide To Alternative Cancer Treatments.

Cooking by whatever means, except for very light steaming, completely destroys all enzymes in food even enzyme rich foods. So this is one of the strengths of the Gerson diet – organic fruit and vegetables for salvestrols and raw for the enzymes.

Advocates of the enzyme theory believe that if the diet consists almost entirely of enzyme-dead, cooked and processed foods, the body’s own production of digestive enzymes by the pancreas, will become exhausted and depleted by the effort to digest food. Essentially the pancreas has to do all the work that should be done in part by enzymes naturally occurring in uncooked food.

Enzymes digest cancer’s cell wall so that other agents can penetrate and kill the rest of the cell. Dr. William Kelley promoted an enzyme therapy and according to his extensive case study records, digested a tumour in four weeks. His work is carried on by Dr. Nicholas Gonzales.

Another cancer-fighter, the T-lymphocyte, attacks cancer cells in a similar manner, utilizing enzymes in its ability to dissolve and digest tumour cells.

Proteolytic enzymes from the pancreas have the unique ability to break down the muco-protein coating that encases all malignant tumours and protects cancer cells from attack by the body’s immune system.

Taking enzymes on an empty stomach is reported to:
• Digest proteins
• Assimilate fats
• Increase energy
• Reduce bacteria
• Eliminate yeast
• Break up and dissolve uric acid crystals
• Raise T-Cell activity and production
• Stimulate the Immune System
• Shatter crystalline deposits
• Break up cholesterol deposits
• Increase the white blood cell size and activity
• Increase the surface area of the red blood cells, to carry more oxygen to all the parts of the body

That’s just a little bit as food for thought. Could enzymes assist salvestrols in being effective for more people, bearing in mind that enzyme therapy is a purported cancer cure in itself?


RE: Salvestrol

by bigsky20 on Fri Mar 22, 2013 01:18 AM

Quote | Reply

Macdon,

I've been researching that myself and I've been looking at Nattokinase, vitalzym, proteolytic enzymes, buluoke. I'm looking at dissolving fibrin because my tumor is wrapped up in scar tissue.

I'm not taking Salvestrols at this time. For those of you that are, I've been looking at Modified Citrus Pectin by Dr. Eliaz. Maybe you all have heard of it already. It also comes from tangerine peels, apple peels etc. It's used for detoxing heavy metals in a safe effective way. He combines his with alginate. I think that it might be another supplement to add to one's protocol with Salvestrol. Here is the link:http://www.econugenics.com/showproduct.aspx?ProductID=70&

It's cheaper if you purchase it from vitacost.com .

RE: Salvestrol

by pradapee on Fri Mar 22, 2013 01:29 AM

Quote | Reply

agree we should get back on track re salvestrols.   Ive only been taking them for five weeks so cannot report on their efficiency till I get a scan in September.....   just to  clarify are you suggesting we just eat more raw food for the enzymes?  surely this is the job of the salvesrols ... I take 6000 points platinum per day.  Would be interesting if more people reported on their experiences .....still very few case histories on line but perhaps they are very new to the market. 

RE: Salvestrol

by bigsky20 on Fri Mar 22, 2013 02:48 AM

Quote | Reply

Macdon, this is pretty interesting. 

"CANCER METASTASIS

What to fear most if faced by a cancer diagnosis is the spread of the cancer to other parts of the body. This process called metastasis accounts for over 90% of cancer patient deaths and therefore is a strong focus for cancer researchers. Researchers at BRIC, University of Copenhagen have shown that the enzyme Lysyl Oxidase (LOX) can create a “scarred” microenvironment that enhances cancer spreading. By blocking activity of the LOX enzyme, the researchers succeeded in significantly decreasing metastasis in a model of breast cancer." 'When we inhibit the activity of LOX in our cancer models, we show a dramatic reduction in metastasis. This suggests that therapeutic targeting of LOX can keep the tumour microenvironment “healthy” and thereby decrease metastasis, says Associate Professor Janine Erler from BRIC, who has headed the research.

The article can be found herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a

The use of curcumin: "existing evidence indicates that curcumin regulates LOX and COX-2 predominately at the transcriptional level and, to a certain extent, the posttranslational level."http://www.ncbi.nlm.nih.gov/pubmed/17569213

Boswella and LOX: "Modern researchers first validated boswellia's medical relevance with the discovery of boswellic acids. One in particular,AKBA (3-acetyl-11-keto-betaboswellic acid), was shown to bind directly to the 5-LOX enzyme in our bodies, preventing it from facilitating production of pro-inflammatory leukotrienes.39"

A good supplement of Boswella can be found here along with the above article:http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth

Maybe these supplements can help with Salvestrols too. I know that mostly everyone is taking curcumin, but I'm not sure if everyone knows about Boswella. I sure didn't.

 

RE: Solvestrols at work

by kimcooney on Fri Mar 22, 2013 10:03 AM

Quote | Reply

On Mar 08, 2013 7:53 PM mastergreener wrote:

How much are you paying now and where are you located?

$171AU for 90 capsules. Located NSW Australia.

RE: Salvestrol

by AJoan on Fri Mar 22, 2013 10:16 AM

Quote | Reply

On Mar 22, 2013 2:48 AM bigsky20 wrote:

Macdon, this is pretty interesting. 

"CANCER METASTASIS

What to fear most if faced by a cancer diagnosis is the spread of the cancer to other parts of the body. This process called metastasis accounts for over 90% of cancer patient deaths and therefore is a strong focus for cancer researchers. Researchers at BRIC, University of Copenhagen have shown that the enzyme Lysyl Oxidase (LOX) can create a “scarred” microenvironment that enhances cancer spreading. By blocking activity of the LOX enzyme, the researchers succeeded in significantly decreasing metastasis in a model of breast cancer." 'When we inhibit the activity of LOX in our cancer models, we show a dramatic reduction in metastasis. This suggests that therapeutic targeting of LOX can keep the tumour microenvironment “healthy” and thereby decrease metastasis, says Associate Professor Janine Erler from BRIC, who has headed the research.

The article can be found herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a nd_metastasis"" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a

The use of curcumin: "existing evidence indicates that curcumin regulates LOX and COX-2 predominately at the transcriptional level and, to a certain extent, the posttranslational level."http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213

Boswella and LOX: "Modern researchers first validated boswellia's medical relevance with the discovery of boswellic acids. One in particular,AKBA (3-acetyl-11-keto-betaboswellic acid), was shown to bind directly to the 5-LOX enzyme in our bodies, preventing it from facilitating production of pro-inflammatory leukotrienes.39"

A good supplement of Boswella can be found here along with the above article:http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth al-Enzyme_01.htm"" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth

Maybe these supplements can help with Salvestrols too. I know that mostly everyone is taking curcumin, but I'm not sure if everyone knows about Boswella. I sure didn't.

 

That's amazing. I see that Life Extension sells the Boswellia extract. You can call a number there to ask questions: 1 800 864 3027.

It sounds like it should be compatible with salvestrols. Don't dare ask Gerry any more questions, he's inundated.

Thank you for posting this.

RE: Salvestrol

by bigsky20 on Fri Mar 22, 2013 11:11 AM

Quote | Reply

On Mar 22, 2013 10:16 AM AJoan wrote:

On Mar 22, 2013 2:48 AM bigsky20 wrote:

Macdon, this is pretty interesting. 

"CANCER METASTASIS

What to fear most if faced by a cancer diagnosis is the spread of the cancer to other parts of the body. This process called metastasis accounts for over 90% of cancer patient deaths and therefore is a strong focus for cancer researchers. Researchers at BRIC, University of Copenhagen have shown that the enzyme Lysyl Oxidase (LOX) can create a “scarred” microenvironment that enhances cancer spreading. By blocking activity of the LOX enzyme, the researchers succeeded in significantly decreasing metastasis in a model of breast cancer." 'When we inhibit the activity of LOX in our cancer models, we show a dramatic reduction in metastasis. This suggests that therapeutic targeting of LOX can keep the tumour microenvironment “healthy” and thereby decrease metastasis, says Associate Professor Janine Erler from BRIC, who has headed the research.

The article can be found herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a nd_metastasis"" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a "" target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a target="_blank" rel="nofollow">herehttp://news.ku.dk/all_news/2013/2013.1/tissue_scarring_a

The use of curcumin: "existing evidence indicates that curcumin regulates LOX and COX-2 predominately at the transcriptional level and, to a certain extent, the posttranslational level."http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 "" target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213 " target="_blank" rel="nofollow">http://www.ncbi.nlm.nih.gov/pubmed/17569213

Boswella and LOX: "Modern researchers first validated boswellia's medical relevance with the discovery of boswellic acids. One in particular,AKBA (3-acetyl-11-keto-betaboswellic acid), was shown to bind directly to the 5-LOX enzyme in our bodies, preventing it from facilitating production of pro-inflammatory leukotrienes.39"

A good supplement of Boswella can be found here along with the above article:http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth al-Enzyme_01.htm"" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth "" target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth target="_blank" rel="nofollow">http://www.lef.org/magazine/mag2011/ss2011_Neutralize-a-Leth

Maybe these supplements can help with Salvestrols too. I know that mostly everyone is taking curcumin, but I'm not sure if everyone knows about Boswella. I sure didn't.

 

That's amazing. I see that Life Extension sells the Boswellia extract. You can call a number there to ask questions: 1 800 864 3027.

It sounds like it should be compatible with salvestrols. Don't dare ask Gerry any more questions, he's inundated.

Thank you for posting this.

You're welcom Joan!

As I read further into the night, I saw that boswella works on 5-Lox. It's the same family of Lox, but I don't know if it works on the whole group. Here is an explanation:

5-lipoxygenase (5-LOX) is a member of the lipoxy-genase family of enzymes. It transforms fatty acids into leukotrienes. Excess levels of the enzyme5-LOXsets in motion inflammatory responses that have been linked to common degenerative effects in aging individuals.9-13

5-LOXbreaks downarachidonic acidto pro-inflam­matory compounds like leukotrieneB4,14a molecule that mediates attacks to joints, arterial walls, and other tissues.5-LOXitself facilitates undesirable cell division changes.15,16

The good news is that an extract of the Indian plant Boswellia serrata has been shown to neutralize 5-LOX. Used for centuries to help with inflammatory issues,boswellia acts as a natural5-LOX inhibitor, intervening at the cellular level to block its unwanted effects. Confirmatory data reveal that a compound contained inboswellia calledAKBA(3-O-acetyl-11-keto-ß-boswellic acid)17,18 is the key to its beneficial action.

The problem is thatboswelliais poorly absorbed into the blood.19For this reason, a patent-pending, standardized form ofboswelliacalledAprèsFlex™ is being introduced. AprèsFlex™ absorbs into the blood52%more than previously availableboswelliaextracts.19

Each100mg vegetarian capsule of5-LOX Inhibitor with AprèsFlex™ is standardized to provide 20% of activeAKBAfromboswellia. Most people need only one capsule a day.

 

Now, if you go to the site I listed below. Scroll down to the very bottom and you'll find LOX inhibitors. One's that you won't even recognize other than curcumin and baicalaine (Boswella). If boswella blocks both the 5-Lox and Lox enzyme, we've struck gold because Life Extensions bioavailable Boswella (Apresflex) is a whopping $22.00's. :)

Here is the site and scroll down to the bottom so that you can see a list of Lox inhibitors:http://www.emdmillipore.com/life-science-research/lipoxygena  " target="_blank" rel="nofollow">http://www.emdmillipore.com/life-science-research/lipoxygena

http://www.emdmillipore.com/life-science-research/lipoxygena

 

RE: Salvestrol

by bigsky20 on Fri Mar 22, 2013 11:16 AM

Quote | Reply

Sorry about the copy of the extra long quote. It seems as if we quote the same post with links over and over, it gets longer and longer. It slightly annoys me!

1623 Posts | Page(s): Prev 12...73 74 75 76 77 ...162163 Next 
Subscribe to this message board discussion

Latest Messages

View More

We care about your feedback. Let us know how we can improve your CancerCompass experience.